2BB score and signals
Latigo Biotherapeutics, Inc.’s current 2BB score is 54 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 63 | High |
| Momentum | 49 | Stable |
| Financial strength | 0 | Very Weak |
| Quality | 76 | Strong |
Latigo Biotherapeutics, Inc. (LTGO) Stock Score & Signals
Latigo Biotherapeutics, Inc. (LTGO) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 54 out of 100.
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2026-09-03 | -27.59 | -0.5661 | $0.00 | $0.00 |